This is a $169,400.44 firm fixed-price purchase order contract awarded to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The contract is with the Department of Veterans Affairs' Veterans Integrated Service Network 22 and does not have a set-aside designation. Through this award, Roche Diagnostics will provide reagents to support medical testing and laboratory operations at VA facilities. Roche Diagnostics has a history of providing...
This $222,918.10 firm fixed-price delivery order contract was awarded by the Veterans Integrated Service Network 10 of the Department of Veterans Affairs to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for the provision of reagents and supplies, with a period of performance through January 31, 2026. Roche Diagnostics holds several indefinite delivery contracts and...
This federal contract award is for reagents with a ceiling value of $34,397.44. The prime contractor is Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract was awarded by the U.S. Department of Veterans Affairs (VA) through the Veterans Integrated Service Network 1 (VISN 1), with an ultimate completion date of August 14, 2025. Roche...
This federal contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $190,272.34 firm fixed-price purchase order is for the delivery of VENTANA REAGENTS with a completion date of November 24, 2021. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and associated...
This is a $102,970.11 firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for REAGENTS and has no set-aside designation. Roche Diagnostics has provided critical medical equipment, supplies, and services to the VA, Department of Defense, Department of Health and Human Services, and...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a $133,694.18 firm fixed-price purchase order to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The award is for the delivery of reagents to support the VA's healthcare services for veterans, with a performance period ending on November 4, 2022. Roche Diagnostics has a history of providing critical care analyzers, reagents, test kits, and associated...
This is a $400,033 firm fixed price purchase order awarded by the Veterans Integrated Service Network 22 (VISN 22) of the U.S. Department of Veterans Affairs to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of medical diagnostic products and equipment. The contract is for the delivery of reagents, with a period of performance through August 10, 2025. Roche Diagnostics has previously received other prime and subcontract awards from the VA, Department of Defense,...
This federal contract award to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, and related laboratory equipment, was made by the Department of Veterans Affairs (VA) through Veterans Integrated Service Network 23. The $323,373.27 firm fixed-price purchase order is for the supply of reagents with a period of performance ending on March 31, 2018. The contract has no set-aside designation. Roche Diagnostics has a long history of providing critical...
The U.S. Department of Veterans Affairs (VA) awarded a $194,833.19 firm-fixed-price delivery order contract to Roche Diagnostics Corporation for the provision of reagents. This contract has an ultimate completion date of October 15, 2026. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract does not have a set-aside designation. Roche Diagnostics has previously received awards from the...
This federal contract award to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics, reagents, and laboratory equipment, provides $553,387.58 in firm fixed-price funding for the supply of reagents and consumables. The contract was awarded on October 10, 2024 by the Department of Veterans Affairs' Veterans Integrated Service Network 22, a civilian agency, with an ultimate completion date of April 9, 2025. The contract is not set aside for any specific business type. Roche...